SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-088662
Filing Date
2024-07-31
Accepted
2024-07-31 16:47:26
Documents
2
Period of Report
2024-07-29

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2132
2 EX-24.1 nktx-ex24_1.htm EX-24.1 12382
  Complete submission text file 0000950170-24-088662.txt   15940
Mailing Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 (925) 407-1049
Nkarta, Inc. (Issuer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address
Mahmood Nadir (Reporting) CIK: 0001816598 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39370 | Film No.: 241162684